Arient Scientific Private Limited

Arient Scientific Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials and compliance.
CIN U33110MH2013PTC245663 Incorporated 15 July 2013 ROC Mumbai HQ Thane, Maharashtra, India
Under Insolvency Private Limited Company pharma
Data last updated
Revenue · FY 2016
₹5.46 Cr
▲ 35.00% YoY
EBITDA · FY 2016
*****
▼ 7.00% YoY
Net profit · FY 2016
*****
▲ 660.00% YoY
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹86.19 Lakh
Issued & subscribed
Open charges
₹48 Lakh
Secured borrowings
Company age
13 yrs
Est. 2013
Last financials
Mar 2016
Balance sheet date

About Arient Scientific Private Limited

Data last updated: 22 July 2025

Arient Scientific Private Limited is a private limited company based in Thane, Maharashtra, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 15 July 2013, the company has been in operation for over 13 years.

Registered with ROC Mumbai under CIN U33110MH2013PTC245663.

Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹86.19 Lakh. It is led by directors including Jeetendra Rajpal Daryani and Kailas Sakharam Bhoir.

Last AGM: 30 September 2016. Financial statements filed for year ended 31 March 2016. Office: Thane, Maharashtra.

As per the financials filed for FY 2016, the company reported a revenue of ₹5.46 Cr, a growth of 35% compared to the previous year.

As per MCA filings, the company has open charges of ₹48 Lakh on record.

The company is undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional, and the company may not be able to independently enter into new commitments.

Company Details of Arient Scientific Private Limited
CIN U33110MH2013PTC245663
Registration Number 245663
Incorporation Date 15 July 2013
ROC Mumbai
Listing Status Unlisted
Company Status Under CIRP
Date of Last AGM 30 September 2016
Date of Balance Sheet 31 March 2016
Compliance Status Active Non-Compliant
Key People
Jeetendra Rajpal Daryani Irp/Rp/Liquidator Kailas Sakharam Bhoir Director Ashish Narayan Sakalkar Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    C – 402 Siddheshwar Palms Kalyanshil Road Near Khidkaleshwar Mandir Opp Desai Nak, A, Thane, Maharashtra, India – 421204
  • Industry
    Pharma, Drug Formulation & Development
Company report
Arient Scientific Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Arient Scientific Private Limited report

Financials, compliance, directors, charges, ownership and filings for Arient Scientific Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Arient Scientific Private Limited

Arient Scientific Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Arient Scientific Private Limited

Arient Scientific Private Limited is audited by S D R M & ASSOCIATES for the financial year 2016. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
S D R M & ASSOCIATES blur-value blur-value blur-value

Board of Directors of Arient Scientific Private Limited

Arient Scientific Private Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Jeetendra Rajpal Daryani Irp/Rp/Liquidator 30 Aug 2024 1 Years 10 Months As last reported
Kailas Sakharam Bhoir Director 15 Jul 2013 12 Years 11 Months As last reported
Ashish Narayan Sakalkar
Also directs: Ferron Lifecare Private Limited, Asston Pharmaceuticals Limited
Director 15 Jul 2013 12 Years 11 Months As last reported
View all directors

Financials of Arient Scientific Private Limited FY 2016 filings available

Arient Scientific Private Limited reported revenue of ₹5.46 Cr (up 35% YoY) for FY 2016. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹5.46 Cr ▲ 35%
Profit
***** ▲ 660%
EBITDA
***** ▼ -7%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Arient Scientific Private Limited

As of FY 2016, Arient Scientific Private Limited's shareholding pattern shows 93.04% by promoters, 6.96% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Arient Scientific Private Limited

Open charges
₹48 Lakh
Satisfied charges
₹0
Breakdown by lending institutions
Central Bank of India Limited₹0.48 Cr
Latest charge details
DateLenderAmountStatus
07 Dec 2013 Central Bank of India Limited ₹48 Lakh Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Arient Scientific Private Limited

View historical data on people associated with Arient Scientific Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Arient Scientific Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Arient Scientific Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Arient Scientific Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Arient Scientific Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Arient Scientific Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Arient Scientific Private Limited

MSME Payment Delays by Arient Scientific Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Arient Scientific Private Limited

Subsidiaries & Group Companies of Arient Scientific Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Arient Scientific Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Arient Scientific Private Limited

MCA Filings & Documents of Arient Scientific Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Arient Scientific Private Limited

Directors
30 Aug 2024
Jeetendra Rajpal Daryani was appointed as a IRP/RP/Liquidator on 30 Aug 2024 & has been associated with this company since 1 year 10 months.
Activity
30 Sep 2016
Arient Scientific Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records.
Activity
31 Mar 2016
Arient Scientific Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai.
Charges
07 Dec 2013
A charge with Central Bank Of India Limited amounted to Rs. 0.48 Cr with Charge ID 10470282 was registered on 07 Dec 2013.
Directors
15 Jul 2013
Kailas Sakharam Bhoir was appointed as a Director on 15 Jul 2013 & has been associated with this company since 12 years 11 months.
Directors
15 Jul 2013
Ashish Narayan Sakalkar was appointed as a Director on 15 Jul 2013 & has been associated with this company since 12 years 11 months.

Frequently Asked Questions about Arient Scientific Private Limited

Arient Scientific Private Limited is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.

Arient Scientific Private Limited is a company under insolvency, formerly operating as a private limited company in the pharma sector based in Thane, Maharashtra, India. It was incorporated on 15 July 2013 and is registered under CIN U33110MH2013PTC245663. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

Arient Scientific Private Limited reported revenue of ₹5.46 Cr for FY 2016 (up 35.00% YoY).

The current directors of Arient Scientific Private Limited are:

The CIN (Corporate Identification Number) of Arient Scientific Private Limited is U33110MH2013PTC245663. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Arient Scientific Private Limited has open charges of ₹48 Lakh and no satisfied charges on record as per latest MCA filings.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available